CORC

在结果中检索

CORC

浏览/检索结果: 共13条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 期刊论文
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897
作者:  Lu, Tingting;  Cao, Jiangyan;  Zou, Fengming;  Li, Xixiang;  Wang, Aoli
收藏  |  浏览/下载：42/0  |  提交时间：2021/04/26
Deciphering the mechanism of Indirubin and its derivatives in the inhibition of Imatinib resistance using a "drug target prediction-gene microarray analysis-protein network construction" strategy 期刊论文
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 卷号: 19
作者:  Li, Huayao;  Liu, Lijuan;  Zhuang, Jing;  Liu, Cun;  Zhou, Chao
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronice-Phase Chronic Myeloid Leukemia 期刊论文
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 卷号: 18, 期号: 10
作者:  Cui, Jiu Wei;  Kim, Hawk;  Kim, SooHyun;  Kim, Hyeoung-Joon;  Kim, Yeo-Kyeoung
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance 期刊论文
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 卷号: 542, 期号: 1-2
作者:  Chen, Yan;  Cheng, Yao;  Zhao, Pengxuan;  Zhang, Shasha;  Li, Minsi
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia 期刊论文
Biochemical and Biophysical Research Communications, 2018, 卷号: 507, 期号: 1-4, 页码: 1-8
作者:  Wen, Feng*;  Cao, Yi-Xiong;  Luo, Ze-Yu;  Liao, Pei;  Lu, Zhong-Wei
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/27
[The Roles of Glut5 in Imatinib Resistance in the Ph+ Acute Lymphoblastic Leukemia Cell]. 期刊论文
Sichuan Da Xue Xue Bao Yi Xue Ban, 2017, 卷号: Vol.48 No.3, 页码: 389-393
作者:  Yan TY;  Naren DL;  Gong YP.
收藏  |  浏览/下载：2/0  |  提交时间：2019/03/01
The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells 期刊论文
2017, 卷号: 22, 期号: 4, 页码: 208-216
作者:  Wang, Haiying;  Li, Qian;  Tang, Shusen;  Li, Meifang;  Feng, Anhua
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/04
Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo 期刊论文
CANCER SCIENCE, 2016, 卷号: 107, 期号: 6, 页码: 782-790
作者:  Wang, Wenqian;  Liu, Yang;  Zhao, Zhixin;  Xie, Chengying;  Xu, Yongping
收藏  |  浏览/下载：14/0  |  提交时间：2019/01/08
Characteristics of the TCR V beta repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations (SCI收录) 期刊论文
SCIENCE CHINA-LIFE SCIENCES, 2015, 卷号: 58, 页码: 1276-1281
作者:  Xu Ling[1];  Lu YuHong[2];  Lai Jing[1,2];  Yu Wei[3];  Zhang YiKai[1]
收藏  |  浏览/下载：3/0  |  提交时间：2019/04/25
Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro 期刊论文
ACTA PHARMACOLOGICA SINICA, 2014, 卷号: 35, 期号: 3, 页码: 401-409
作者:  Wu, Li-xian;  Wu, Ying;  Chen, Rui-jia;  Liu, Yang;  Huang, Li-sen
收藏  |  浏览/下载：20/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace